$PATH

UiPath, Inc.

UiPath provides enterprise software for automating and orchestrating business processes, serving organizations across industries including financial services, insurance, healthcare, public sector, retail, supply chain, and manufacturing. Its UiPath Platform combines AI agents, software robots, people, and models in coordinated workflows. The platform includes process orchestration and mining, tools to build AI agents and UI or API automations, document data extraction and processing, agentic software testing, and packaged solutions for industry-specific uses. It also offers centralized governance and security features and SaaS, self-hosted, and hybrid deployment options. UiPath sells through a direct sales team, channel partners, and systems integrators, and provides professional services to support customer adoption. Its principal executive offices are in New York, New York.

0
0
3
—
$771K
Brubaker Brad
100%
See all $PATH insider activity →
Low

UiPath vs. Palantir Technologies: Comparing Modest Revenue Growth vs. Rapid Expansion

Palantir (PLTR) reported rapid revenue growth, doubling over eight quarters, while UiPath (PATH) saw modest, seasonal growth. Palantir's Q3 revenue was $2.3B, with commercial sales surpassing government revenue. UiPath's Q2 revenue was $410.3M, up 13% YoY, but growth is decelerating. Both companies are in enterprise AI, with Palantir showing stronger demand.

PATH sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning PATH (UiPath, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 3 bearish.

Recent PATH coverage spans financial news, market movers and technology.

In the last 30 days, PATH insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($771K). The most active reporter was Brubaker Brad, Chief Legal & Admin Officer, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving PATH

AlphAI scores every news story that mentions PATH with an AI model for sentiment and relevance, and aggregates insider trades from UiPath, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PATH

Score

UiPath vs. SentinelOne: Which Technology Stock Is a Better Buy for 2027?

UiPath and SentinelOne are compared for long-term investment potential. UiPath has a debt-to-equity ratio of 0.0x, a current ratio of 1.4x, and free cash flow of $75.9 million, but faces risks from competition and customer concentration. SentinelOne, despite net losses, shows faster growth and raised its full-year outlook. UiPath is valued cheaper, but SentinelOne is preferred for its growth and AI security focus.

Okta vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

Okta (OKTA) and UiPath (PATH) are compared as potential tech stock investments for 2026. Okta focuses on identity security, serving 20,000+ customers, with FY 2026 revenue of $2.9B and net income of $235M. UiPath specializes in automation, reporting FY 2026 revenue of $1.6B and net income of $282.3M. Both show growth but face competition and risks. Okta trades at higher valuation multiples.

Top infrastructure software stocks ahead of earnings: BofA Securities

BofA Securities identifies infrastructure software as an attractive sector, highlighting Datadog (DDOG) and Atlassian (TEAM) as top picks. The firm expects AI to drive growth and raised price targets for both. DDOG's security offerings crossed $100M in annual recurring revenue, while TEAM's Cloud revenue growth is a key metric. BofA maintains Buy ratings for both, with new price targets of $335 for DDOG and $252 for TEAM.

Top insider buys and sells disclosed on Tuesday

Insider trading activity for US-listed stocks on Tuesday included significant purchases and sales. Saba Capital bought 338,104 shares of BNY Mellon Strategic Municipals (LEO) at $5.63-$5.67. Nippon Life bought 347,195 shares of Corebridge Financial (CRBG) at $34.31-$35.07. Kevin Tang increased his stake in Boundless Bio (BOLD) with purchases totaling $349,592. Smriti Popenoe bought $156,560 of Dynex Capital (DX) stock. David Sims acquired $108,632 of Eagle Capital Growth Fund (GRF) shares.

UiPath vs. Snowflake: Which Technology Stock Is a Better Buy in 2026?

UiPath and Snowflake face distinct challenges. UiPath deals with competitive pressure, customer concentration, and regulatory risks, while Snowflake competes with major cloud providers, has unpredictable revenue, and cybersecurity threats. UiPath is valued lower on forward P/E, while Snowflake has a higher P/S ratio. UiPath is profitable with low debt, whereas Snowflake is not yet profitable but growing rapidly.

Related tickers